ArticleChemistry (Weinheim an der Bergstrasse, Germany)2025
Mn
Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
L2 is a bisamide derivative of cyclohexyl-diamine tetraacetate (CDTA) containing one trifluoromethyl-piperidine- and one dimethyl-amide. While the amide functions are stable at pH 7, at pH 4.35 hydrolysis occurs after 1 day, and it is faster for the amide involving the piperidine. pH potentiometry showed lower basicity for L2 than for CDTA, and similar stability for the two complexes (pMn = 8.28 vs. 8.68 for MnL2 and MnCDTA, respectively). The replacement of carboxylates by amides results in two orders of magnitude higher kinetic inertness for MnL2 (t
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.